Article

Future-proofing coagulation labs: The importance of digitalizing lab workflow management for data-driven diagnosis

Published on December 4, 2025 | 5 min read

Key takeaways

  • Coagulation labs are tasked with large testing volumes and budget constraints
  • Manual and fragmented workflows cause inconsistencies and inefficiencies, leading to errors and longer turnaround times for diagnostic results
  • Digitalizing lab workflows, including using middleware and advanced algorithms, helps scale operations while providing patients with faster diagnosis

Laboratories are facing increasing pressure to deliver diagnostic results faster, handle greater test volumes, and manage increasingly complex data. These challenges are particularly evident in coagulation testing, where timely and accurate diagnostics are critical for managing blood disorders like thrombophilia and hemophilia.1 To meet these demands, laboratory managers and directors must move away from traditional manual processes and embrace digital workflows and data-driven diagnostic approaches in order to fundamentally transform their lab workflow management.

The limitations of manual and fragmented workflows

Today's healthcare landscape requires coagulation labs to process more tests rapidly while maintaining accuracy and compliance. Rising demand, combined with a shortage of skilled laboratory personnel and budget constraints, exacerbates the inefficiencies inherent in manual and fragmented systems.2 Manual data entry and stand-alone instruments often lead to transcription errors, prolonged turnaround times, and difficulty maintaining comprehensive data integrity, adversely affecting patient care and operational efficiency.3

This inefficiency poses risks, particularly when critical results like prothrombin time (PT) directly influence patient treatments, such as anticoagulation therapy.4

The role of digital integration and middleware: Efficiency through automation

Digitalizing lab workflows, primarily through middleware linking laboratory instruments with laboratory information systems (LIS), aids in the operational dynamics of coagulation labs. Middleware facilitates seamless communication between instruments and LIS, automating the transfer and validation of test results.5 Through such integrated digital solutions, lab leaders can rapidly and consistently verify routine test outcomes, freeing laboratory professionals to focus on complex cases requiring expert analysis. This digital integration also ensures comprehensive and centralized data management, which enhances clinical decision-making by allowing quick access to aggregated patient and test data.5,6

Also enabled by middleware and digital solutions, automated ratio calculations significantly enhance consistency across laboratory workflows. Such calculations include the international normalized ratio (INR), which is used in coagulation testing to standardize results for managing anticoagulation therapies.7 By replacing manual computations with automated processes, laboratories reduce errors and achieve greater accuracy in diagnostic results. This approach empowers lab professionals to make informed physician decisions swiftly, leading to optimized patient care and improved resource allocation.

Data-driven diagnostics and clinical decision support

Adopting data-driven diagnostic tools allows laboratories to enhance their clinical support capabilities. This is aided by advanced analytics and algorithms, specifically useful for interpreting complex coagulation profiles to predict thrombotic risks or manage anticoagulant therapy more effectively.1,4,8 Integrating data from tests like fibrinogen levels, platelet counts, and anticoagulant monitoring enables predictive models to stratify patient risks accurately, guiding clinicians in personalized patient management. This analytical approach improves the precision and effectiveness of treatment strategies for complex coagulation disorders, resulting in better patient outcomes.9

Digital solutions and a cohesive digital laboratory workflow also improve quality control management, making it easier to maintain compliance with stringent regulatory requirements. For example, automated quality control procedures ensure continuous monitoring of test accuracy, promptly identifying deviations that could compromise patient results.10 Digital systems automatically document quality assurance activities, simplifying audit trails and demonstrating adherence to compliance standards such as clinical laboratory improvement amendments (CLIA).11 Comprehensive traceability of test samples and results further strengthens regulatory readiness and enhances laboratory accountability.12

Benefits of advanced integration

Embracing digital workflows positions coagulation laboratories to manage evolving healthcare challenges effectively. Digitalization provides the flexibility required to quickly adapt to new diagnostic methods, emerging diseases, and changing patient demographics. Laboratories utilizing digital platforms can swiftly integrate new diagnostic tests or instruments without disrupting ongoing operations. 

Furthermore, data-driven resource management optimizes reagent usage and staffing, reducing operational costs and minimizing waste. This strategic approach ensures that laboratories remain future-ready, capable of scaling operations sustainably while continuing to deliver high-quality diagnostic services.13

Overall, automated digital solutions that aid in sample processing, data handling, and quality control can streamline workflow management, dramatically reducing turnaround times and improving reliability. Digitization offers increased standardized processes, ensuring that every test is performed under consistent conditions, decreasing variability and improving reproducibility.14

Lab leaders who proactively implement these digital solutions will ensure their laboratories are not only prepared to meet current demands but also strategically positioned to thrive amidst the changing landscape of healthcare diagnostics.

Get our latest insights

Join our community and stay up to date with the latest laboratory innovations and insights.

Continue reading

The evolution of coagulation testing: Trends, challenges, and opportunities

To hear more from Dr. Zengi, why not check out another article in our series titled, The evolution of coagulation testing: Trends, challenges, and opportunities.

Contributor

Headshot of Oguzhan Zengi

Oguzhan Zengi, Assoc. Prof. EuSpLM Director of the Clinical Chemistry Laboratory at Başakşehir Çam and Sakura City Hospital

Assoc. Prof. EuSpLM Oguzhan Zengi is the Director of the Clinical Chemistry Laboratory at Başakşehir Çam and Sakura City Hospital in Istanbul and an Associate Professor of Medical Biochemistry. He has a strong academic and clinical background in laboratory medicine, with special interest in coagulation testing, flow cytometry, automation, and quality management. Assoc. Prof. EuSpLM Zengi has contributed to numerous national and international projects and frequently lectures on laboratory diagnostics, verification processes, and digital transformation in clinical labs.

Subscribe to our newsletter

Get a summary of our most important articles. 
Get invited to our exclusive healthcare webinars. 
Receive our latest insights and ebooks.

References

  1. National Institutes of Health National Library of Medicine. (2025). MedlinePlus. Information available from https://medlineplus.gov/lab-tests/coagulation-factor-tests/ [Accessed March 2025]
  2. Carlson AH. (2023). Clinical Lab Products. Article available from https://clpmag.com/disease-states/infectious-diseases/covid-19/how-labs-are-meeting-the-challenges-of-the-post-pandemic-world/ [Accessed March 2025]
  3. Reithel J. (2021). Medical Laboratory Observer. Article available from https://www.mlo-online.com/continuing-education/article/21230466/minimizing-laboratory-errors-with-automation [Accessed March 2025]
  4. National Institutes of Health National Library of Medicine. (2025). MedlinePlus. Information available from https://medlineplus.gov/lab-tests/partial-thromboplastin-time-ptt-test/ [Accessed March 2025]
  5. The College of American Pathologists. Information available from https://www.cap.org/member-resources/clinical-informatics-resources/the-simple-definitions-dos-and-donts-of-installing-middleware [Accessed March 2025]
  6. Rubenstein C. (2023). Today’s Clinical Lab. Article available from https://www.clinicallab.com/workflow-automation-can-address-the-needs-of-large-and-small-labs-27493 [Accessed March 2025]
  7. Cleveland Clinic. (2024). Information available from https://my.clevelandclinic.org/health/diagnostics/prothrombin-time-test [Accessed March 2025]
  8. White E & Krauss R. (2024). Clinical Leader. Article available from https://www.clinicalleader.com/doc/what-can-advanced-analytics-do-for-clinops-0001 [Accessed March 2025]
  9. Undru TR et al. (2022). Maedica (Bucur) 17, 420-426. Paper available from https://pmc.ncbi.nlm.nih.gov/articles/PMC9375890/ [Accessed March 2025]
  10. Wilson M. (2023). The Medicine Maker. Article available from https://themedicinemaker.com/issues/2023/articles/jun/the-automated-qc-lab-of-the-future/ [Accessed March 2025]
  11. U.S. Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments (CLIA). Information available from https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments [Accessed March 2025]
  12. Beastall GH. (2018). EJIFCC 29, 242-247. Paper available from https://pmc.ncbi.nlm.nih.gov/articles/PMC6295586/ [Accessed March 2025]
  13. Heidt B et al. (2020). Biosensors (Basel) 10, 133. Paper available from  https://pmc.ncbi.nlm.nih.gov/articles/PMC7598644/ [Accessed March 2025]
  14. Munari E et al. (2024). Virchows Arch 484, 555-566. Paper available from https://pmc.ncbi.nlm.nih.gov/articles/PMC11062949/ [Accessed March 2025]